Search company, investor...

Total Raised

$7.22M

Investors Count

7

Deal Terms

2

Funding, Valuation & Revenue

3 Fundings

evoxx technologies has raised $7.22M over 3 rounds.

evoxx technologies's latest funding round was a Acquired for on July 27, 2017.

evoxx technologies's valuation in June 2013 was $20.54M.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

7/27/2017

Acquired

$99M

0

FY undefined

2

6/24/2013

Series B

$99M

$20.54M

0

FY undefined

10

7/5/2010

Series A

$99M

$99M

0

FY undefined

0

Date

7/27/2017

6/24/2013

7/5/2010

Round

Acquired

Series B

Series A

Amount

$99M

$99M

Investors

Valuation

$99M

$20.54M

$99M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

Sources

2

10

0

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

evoxx technologies Deal Terms

2 Deal Terms

evoxx technologies's deal structure is available for 2 funding rounds, including their Series B from June 24, 2013.

Round

Series B

Series A

Funding Date

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

evoxx technologies Investors

7 Investors

evoxx technologies has 7 investors. Advanced Enzyme Technologies invested in evoxx technologies's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

7/27/2017

7/27/2017

1
Acquired

Corporation

India

00/00/0000

00/00/0000

High-Tech Grunderfonds

Subscribe to see more

Venture Capital

Germany

00/00/0000

00/00/0000

Sirius Venture Partners

Subscribe to see more

Venture Capital

Germany

00/00/0000

00/00/0000

Roland Oetker

Subscribe to see more

Angel Investor (Individual)

Germany

00/00/0000

00/00/0000

NRW.Bank

Subscribe to see more

Bank

Germany

First funding

7/27/2017

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

7/27/2017

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

High-Tech Grunderfonds

Sirius Venture Partners

Roland Oetker

NRW.Bank

Rounds

1
Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Venture Capital

Venture Capital

Angel Investor (Individual)

Bank

Location

India

Germany

Germany

Germany

Germany

evoxx technologies Acquisitions

1 Acquisition

evoxx technologies acquired 1 company. Their latest acquisition was Aevotis on January 29, 2015.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/29/2015

$99M

Corporate Majority

2

Date

1/29/2015

Investment Stage

Companies

Valuation

$99M

Total Funding

Note

Corporate Majority

Sources

2

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Compare evoxx technologies to Competitors

A
AOV

AOV specializes in the health and wellness sector, focusing on the production and distribution of dietary supplements. The company offers a wide range of products including multivitamins, minerals, amino acids, fatty acids, phytotherapeutics, antioxidants, and probiotics designed to support various aspects of health such as energy metabolism, immune system, and bone and muscle health. It is based in Almere, Netherlands.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.